Strategies for combining tumor irradiation and gene-mediated immunotherapy to generate potent therapeutic cancer vaccines

被引:0
|
作者
Hillman, Gilda G. [1 ]
Wang, Yu [1 ]
Singh-Gupta, Vinita [1 ]
Zhang, Hao [1 ]
von Hofe, Eric [2 ]
Xu, Minzhen [2 ]
Slos, Philippe [3 ]
机构
[1] Karmanos Canc Ctr, SWU, Detroit, MI USA
[2] Generex Biotechnol Corp, Antigen Express Inc, Worcester, MA USA
[3] Transgene SA, Strasbourg, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:870 / 870
页数:1
相关论文
共 46 条
  • [21] TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
    Lan Huang
    Huaxi Xu
    Guangyong Peng
    Cellular & Molecular Immunology, 2018, 15 : 428 - 437
  • [22] RECEPTOR-MEDIATED CYTOKINE GENE DELIVERY TO TUMOR-CELLS FOR GENERATION OF CANCER VACCINES
    ZATLOUKAL, K
    WAGNER, E
    COTTEN, M
    SCHMIDT, W
    PLANK, C
    BERGER, M
    SALTIK, M
    STINGL, G
    BIRNSTIEL, ML
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 129 - 129
  • [23] Salmonella-based therapeutic strategies: improving tumor microenvironment and bringing new hope for cancer immunotherapy
    He, Xiaoe
    Guo, Jiayin
    Bai, Yanrui
    Sun, Hui
    Yang, Jing
    MEDICAL ONCOLOGY, 2024, 42 (01)
  • [24] Cationic Lipids-Mediated Dual-Targeting of Both Dendritic Cells and Tumor Cells for Potent Cancer Immunotherapy
    Li, Min
    Zhou, Han
    Fang, Minghao
    Qu, Kun
    Wang, Yucai
    ADVANCED FUNCTIONAL MATERIALS, 2023, 33 (46)
  • [25] Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy
    Zhang, Suhang
    Huang, Qibo
    Ji, Tuo
    Li, Qilin
    Hu, Chuanyu
    BIOMARKER RESEARCH, 2024, 12 (01)
  • [26] Engineered Carrier-Free Nanosystem-Induced In Situ Therapeutic Vaccines for Potent Cancer Immunotherapy (vol 16, pg 47270, 2024)
    Zhang, Min
    Zhao, Yifan
    Lv, Bai
    Jiang, Huimei
    Li, Zequn
    Cao, Jie
    ACS APPLIED MATERIALS & INTERFACES, 2025,
  • [27] Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy
    Chen, Jie
    Fang, Huapan
    Hu, Yingying
    Wu, Jiayan
    Zhang, Sijia
    Feng, Yuanji
    Lin, Lin
    Tian, Huayu
    Chen, Xuesi
    BIOACTIVE MATERIALS, 2022, 7 : 167 - 180
  • [28] Effective cellular vaccines generated by in vitro or in vivo modification of tumor cells using gene and non-gene transfer approaches for cancer immunotherapy
    Guo, YJ
    Shen, F
    Xie, TP
    Che, XY
    Wang, XN
    Wu, SG
    Shi, LH
    Zong, M
    Liu, GL
    Anthony, DD
    Wu, MC
    CANCER GENE THERAPY, 1997, 4 (05) : 314 - 315
  • [29] Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
    Harris, CC
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20): : 1442 - 1455
  • [30] In Situ Gene Engineering Approach to Overcome Tumor Resistance and Enhance T Cell-Mediated Cancer Immunotherapy
    Zhang, Di
    Wang, Wenjuan
    Tang, Mingtan
    Qu, Chenghao
    Jiang, Zeyu
    Li, Xuerui
    Luan, Yuxia
    NANO LETTERS, 2025,